Filings For: Acro Biomedical Co., Ltd.
WHO USES CALCBENCH?    Equity Analysts    Corparate Finance & Reporting    Auditors    Academics

GO TO: Recent Comment Letters


Today


ALL   |    All 10-K/Qs   Large   Mid    Small    Micro    |     Earnings Release    Proxy    |   SORT BY :   Most Recent    Company Name 
CompanyTimeSizeViewFinancialsDocumentSECPeriodRevenue MRQAssetsEPS Diluted
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/14/2026 6:12:20 AM Micro View Financials 10-Q SEC 2Q 2026 ending: 6/30/2026 Assets $3,648
ACRO BIOMEDICAL CO., LTD. (ACBM) 5/5/2026 3:31:52 PM Micro View Financials 10-Q SEC 1Q 2026 ending: 3/31/2026 Assets $3,873
ACRO BIOMEDICAL CO., LTD. (ACBM) 2/11/2026 12:54:38 PM Micro View Financials 10-K SEC Y 2025 ending: 12/31/2025 Assets $14,098
ACRO BIOMEDICAL CO., LTD. (ACBM) 11/10/2025 4:34:49 PM Micro View Financials 10-Q SEC 3Q 2025 ending: 9/30/2025 Assets $4,323
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/5/2025 7:22:46 AM Micro View Financials 10-Q SEC 2Q 2025 ending: 6/30/2025 Assets $53,277
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/24/2025 5:33:59 PM Micro View Financials 10-Q SEC 1Q 2025 ending: 3/31/2025 Assets $25,175
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/24/2025 5:33:56 PM Micro View Financials 10-K SEC Y 2024 ending: 12/31/2024 Assets $31,974
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/23/2025 2:44:58 PM Micro View Financials 10-Q SEC 3Q 2024 ending: 9/30/2024 Assets $38,676
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/23/2025 2:34:56 PM Micro View Financials 10-Q SEC 2Q 2024 ending: 6/30/2024 Assets $45,281
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/22/2025 4:05:31 PM Micro View Financials 10-Q SEC 1Q 2024 ending: 3/31/2024 Assets $50,792
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/18/2025 5:34:53 PM Micro View Financials 10-K SEC Y 2023 ending: 12/31/2023 Assets $58,459 EPS -$0.15
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/11/2025 10:06:47 AM Micro View Financials 10-Q SEC 3Q 2023 ending: 9/30/2023 Assets $19,027 EPS -$0.03
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/14/2023 2:58:22 PM Micro View Financials 10-Q SEC 2Q 2023 ending: 6/30/2023 Assets $539,148
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/2/2023 1:07:40 PM Micro View Financials 10-Q SEC 1Q 2023 ending: 3/31/2023 Assets $656,937
ACRO BIOMEDICAL CO., LTD. (ACBM) 7/21/2023 12:47:05 PM Micro View Financials 10-K SEC Y 2022 ending: 12/31/2022 Rev: $658,500 -45.0% Assets $687,486
ACRO BIOMEDICAL CO., LTD. (ACBM) 11/21/2022 3:54:53 PM Micro View Financials 10-Q SEC 3Q 2022 ending: 9/30/2022 Assets $643,648
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/12/2022 4:34:02 PM Micro View Financials 10-Q SEC 2Q 2022 ending: 6/30/2022 Assets $669,331
ACRO BIOMEDICAL CO., LTD. (ACBM) 5/16/2022 12:48:10 PM Micro View Financials 10-Q SEC 1Q 2022 ending: 3/31/2022 Rev: $298,500 +200.0% Assets $728,594
ACRO BIOMEDICAL CO., LTD. (ACBM) 4/15/2022 3:59:33 PM Micro View Financials 10-K SEC Y 2021 ending: 12/31/2021 Rev: $1,197,500 +74.1% Assets $761,077
ACRO BIOMEDICAL CO., LTD. (ACBM) 11/22/2021 3:14:30 PM Micro View Financials 10-Q SEC 3Q 2021 ending: 9/30/2021 Assets $629,828
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/23/2021 3:11:39 PM Micro View Financials 10-Q SEC 2Q 2021 ending: 6/30/2021 Rev: $500,000 Assets $700,365
ACRO BIOMEDICAL CO., LTD. (ACBM) 5/24/2021 3:35:27 PM Micro View Financials 10-Q SEC 1Q 2021 ending: 3/31/2021 Rev: $99,500 -85.5% Assets $938,874
ACRO BIOMEDICAL CO., LTD. (ACBM) 4/2/2021 5:15:14 PM Micro View Financials 10-K SEC Y 2020 ending: 12/31/2020 Rev: $687,964 -49.2% Assets $998,053
ACRO BIOMEDICAL CO., LTD. (ACBM) 11/17/2020 3:43:00 PM Micro View Financials 10-Q SEC 3Q 2020 ending: 9/30/2020 Assets $989,107
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/19/2020 5:03:23 PM Micro View Financials 10-Q SEC 2Q 2020 ending: 6/30/2020 Assets $998,293
ACRO BIOMEDICAL CO., LTD. (ACBM) 5/19/2020 1:05:50 PM Micro View Financials 10-Q SEC 1Q 2020 ending: 3/31/2020 Rev: $687,964 -49.2% Assets $1,019,449
ACRO BIOMEDICAL CO., LTD. (ACBM) 3/27/2020 3:09:41 PM Micro View Financials 10-KT SEC Y 2019 ending: 12/31/2019 Rev: $1,354,000 -83.1% Assets $1,069,464 EPS -$0.01
ACRO BIOMEDICAL CO., LTD. (ACBM) 1/7/2020 1:03:37 PM Micro View Financials 10-K SEC Y 2019 ending: 9/30/2019 Rev: $1,354,000 -83.1% Assets $1,069,464 EPS -$0.01
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/14/2019 2:35:37 PM Micro View Financials 10-Q SEC 3Q 2019 ending: 6/30/2019 Assets $1,081,094
ACRO BIOMEDICAL CO., LTD. (ACBM) 5/15/2019 2:58:34 PM Micro View Financials 10-Q SEC 2Q 2019 ending: 3/31/2019 Assets $1,139,469
ACRO BIOMEDICAL CO., LTD. (ACBM) 2/14/2019 7:10:27 PM Micro View Financials 10-Q SEC 1Q 2019 ending: 12/31/2018 Rev: $1,354,000 -6.3% Assets $1,270,935
Acro Biomedical Co., Ltd. (ACBM) 12/28/2018 4:02:52 PM   View Financials Earnings WIRE Y 2018 Export Earnings Model
ACRO BIOMEDICAL CO., LTD. (ACBM) 12/28/2018 1:46:43 PM Micro View Financials 10-K SEC Y 2018 ending: 9/30/2018 Rev: $8,014,500 +1,471.5% Assets $1,482,829 EPS $0.01
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/14/2018 4:09:50 PM Micro View Financials 10-Q SEC 3Q 2018 ending: 6/30/2018 Rev: $2,199,000 Assets $1,010,107
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/1/2018 5:26:12 PM Micro View Financials 10-Q SEC 2Q 2018 ending: 3/31/2018 Rev: $1,964,000 Assets $867,923
ACRO BIOMEDICAL CO., LTD. (ACBM) 2/14/2018 7:47:34 PM Micro View Financials 10-Q SEC 1Q 2018 ending: 12/31/2017 Rev: $1,445,000 Assets $764,534
ACRO BIOMEDICAL CO., LTD. (ACBM) 1/16/2018 5:16:36 PM Micro View Financials 10-K/A SEC Y 2017 ending: 9/30/2017 Rev: $510,000 Assets $548,310
ACRO BIOMEDICAL CO., LTD. (ACBM) 8/11/2017 3:43:48 PM Micro View Financials 10-Q SEC 3Q 2017 ending: 6/30/2017 Assets $2,500
ACRO BIOMEDICAL CO., LTD. (ACBM) 5/22/2017 1:13:02 PM Micro View Financials 10-Q SEC 2Q 2017 ending: 3/31/2017 Assets $2,000
ACRO BIOMEDICAL CO., LTD. (ACBM) 2/14/2017 3:36:59 PM Micro View Financials 10-Q SEC 1Q 2017 ending: 12/31/2016 Assets $2,391
KILLER WAVES HAWAII, INC (ACBM) 12/16/2016 4:51:42 PM Micro View Financials 10-K SEC Y 2016 ending: 9/30/2016 Assets $2,533
KILLER WAVES HAWAII, INC (ACBM) 8/3/2016 1:55:17 PM Micro View Financials 10-Q SEC 3Q 2016 ending: 6/30/2016 Assets $2,341
KILLER WAVES HAWAII, INC (ACBM) 5/13/2016 8:23:04 AM Micro View Financials 10-Q SEC 2Q 2016 ending: 3/31/2016 Assets $11,742